Comparison of Acute Reduction in Left Ventricular Outflow Tract Pressure Gradient in Obstructive Hypertrophic Cardiomyopathy by Disopyramide Versus Pilsicainide Versus Cibenzoline-Reference-Cited by-同舟云学术

Comparison of Acute Reduction in Left Ventricular Outflow Tract Pressure Gradient in Obstructive Hypertrophic Cardiomyopathy by Disopyramide Versus Pilsicainide Versus Cibenzoline

Published:2010-11 Issue:9 Volume:106 Page:1307-1312
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Kajimoto Katsuya,Imai Taku,Minami Yuichiro,Kasanuki Hiroshi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide;Pollick;N Engl J Med,1982

2. Disopyramide in hypertrophic cardiomyopathy: hemodynamic assessment after intravenous administration;Pollick;Am J Cardiol,1988

3. Acute dose–response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy;Kimball;Am Heart J,1993

4. Muscular subaortic stenosis: prevention of outflow obstruction with propranolol;Flamm;Circulation,1968

5. Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy;Thompson;Br Heart J,1980

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of the treatments for hypertrophic cardiomyopathy;Frontiers in Cardiovascular Medicine;2024-06-03

2. Interventions in Hypertrophic Obstructive Cardiomyopathy;Canadian Journal of Cardiology;2023-12

3. Contractility measurements for cardiotoxicity screening with ventricular myocardial slices of pigs;Cardiovascular Research;2023-10

4. Medical Therapies to Improve Left Ventricular Outflow Obstruction and Diastolic Function in Hypertrophic Cardiomyopathy;JACC: Advances;2023-10

5. Novel molecular insights and potential approaches for targeting hypertrophic cardiomyopathy: Focus on coronary modulators;Vascular Pharmacology;2022-08